King Levoxyl NDA Approval Anticipated In May Ahead of FDA August Deadline

King expects FDA to approve its Levoxyl NDA by the end of May, the company's President and Chief Operating Officer Jeff Gregory said during a conference call Feb. 20.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet